Learn more

FERRER INT

Overview
  • Total Patents
    1,186
  • GoodIP Patent Rank
    32,962
  • Filing trend
    ⇧ 50.0%
About

FERRER INT has a total of 1,186 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 1974. It filed its patents most often in Spain, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are LIGAND PHARMACEUTICALS INCORPORATED, KISSEI FARMAS JUTIKAL KO LTD and SHANGHAI ALLIST PHARMACEUTICAL.

Patent filings per year

Chart showing FERRER INTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Guglietta Antonio 385
#2 Palomer Albert 287
#3 Foguet Rafael 225
#4 Ortiz Jose A 187
#5 Sacristan Aurelio 159
#6 Anglada Luis 155
#7 Castello Josep M 110
#8 Raga Manuel M 85
#9 Guerrero Marta 79
#10 Sallares Juan 71

Latest patents

Publication Filing date Title
WO2020224795A1 Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof
EP3424321A1 Compounds for treating ectoparasite infestation
JP2015166387A 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salt
EP3029024A1 2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
WO2014198880A1 2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
EP2810644A1 Oral formulation for the treatment of cardiovascular diseases
ES2524645A1 oral formulation for the treatment of cardiovascular diseases
EP2436374A1 Ovule for vaginal administration of arasertaconazole
TW201134813A 1-cyclopropyl-8-methyl-7-(5-methyl-6-(methylamino)-3-pyridinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
AU2010350521A1 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
WO2010066756A1 Polymorph ii of an antifungal compound
ES2359708A1 PREPARATION PROCEDURE OF THE (11BETA, 16ALFA) -9-FLUORO-11-HIDROXI-16,17- [1-METHYL-ETHYLENEBIS (OXI)] - 21- [1-OXO- [4- (NITROOXIMETILE) BENZOXI]] PREÑA-1,4-DIEN-3,20-DIONA.
ES2362894A1 PREPARATION PROCEDURE FOR �? CIDO 4-NITRO-OXI-METIL-BENZOICO.
CA2731405A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
EP2266975A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
SI2273985T1 Capsule for the prevention of cardiovascular diseases
EP2177214A1 Solid Oral Dosage Forms and Uses
EP2177209A1 Intravenous solutions and uses
EP2177208A1 Pharmaceutical topical compositions
EP2141161A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents